Budd-Chiari syndrome risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Budd-Chiari syndrome}}
{{Budd-Chiari syndrome}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}}{{Mazia}}
 
{{PleaseHelp}}


==Overivew==
==Overivew==
Approximately 80 percent of [[patients]] with the Budd-Chiari syndrome have an underlying [[disorder]]. Many patients may have more than one [[risk factor]]. Same patient may have multiple [[causes]] that predispose to the [[development]] of Budd-Chiari Syndrome. Associated risk factors include hematologic disorders, [[coagulopathies]], [[chronic]] [[infections]], [[chronic]] [[inflammatory diseases]], [[tumors]], congenital membranous obstructions.
Approximately 80 percent of [[patients]] with the Budd-Chiari syndrome have an underlying [[disorder]]. Many patients may have more than one [[risk factor]]. Same patients may have multiple [[causes]] that predispose to the [[development]] of Budd-Chiari Syndrome. Associated risk factors include [[hematologic]] disorders, [[coagulopathies]], [[chronic]] [[infections]], [[chronic]] [[inflammatory diseases]], [[tumors]], [[congenital]] membranous obstructions.


==Risk Factors==
==Risk Factors==
*Approximately 80 percent of [[patients]] with the [[Budd-Chiari syndrome]] have an underlying disorder. Many [[patients]] may have more than one [[Risk factors|risk factor]]. Same [[patient]] may have multiple [[causes]] that predispose to the [[development]] of Budd-Chiari Syndrome.<ref name="pmid26668741">{{cite journal |vauthors=Martens P, Nevens F |title=Budd-Chiari syndrome |journal=United European Gastroenterol J |volume=3 |issue=6 |pages=489–500 |year=2015 |pmid=26668741 |pmc=4669515 |doi=10.1177/2050640615582293 |url=}}</ref><ref name="pmid27326316">{{cite journal |vauthors=Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS |title=Redefining Budd-Chiari syndrome: A systematic review |journal=World J Hepatol |volume=8 |issue=16 |pages=691–702 |year=2016 |pmid=27326316 |pmc=4909431 |doi=10.4254/wjh.v8.i16.691 |url=}}</ref>
*Approximately 80 percent of [[patients]] with the [[Budd-Chiari syndrome]] have an underlying disorder. Many [[patients]] may have more than one [[Risk factors|risk factor]]. Same [[patient]] may have multiple [[causes]] that predispose to the [[development]] of Budd-Chiari Syndrome.<ref name="pmid26668741">{{cite journal |vauthors=Martens P, Nevens F |title=Budd-Chiari syndrome |journal=United European Gastroenterol J |volume=3 |issue=6 |pages=489–500 |year=2015 |pmid=26668741 |pmc=4669515 |doi=10.1177/2050640615582293 |url=}}</ref><ref name="pmid27326316">{{cite journal |vauthors=Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS |title=Redefining Budd-Chiari syndrome: A systematic review |journal=World J Hepatol |volume=8 |issue=16 |pages=691–702 |year=2016 |pmid=27326316 |pmc=4909431 |doi=10.4254/wjh.v8.i16.691 |url=}}</ref>
*Associated [[risk factors]] include:
*Associated [[risk factors]] include:
*Hematologic disorders including:
*[[Hematologic]] disorders including:
**[[Polycythemia rubra vera]]
**[[Polycythemia rubra vera]]
**[[Paroxysmal nocturnal hemoglobinuria]]
**[[Paroxysmal nocturnal hemoglobinuria]]
Line 36: Line 34:
**[[Systemic lupus erythematosus]]
**[[Systemic lupus erythematosus]]
**[[Sjögren's Syndrome|Sjögren syndrome]]
**[[Sjögren's Syndrome|Sjögren syndrome]]
**Mixed connective-tissue disease  
**[[Mixed connective tissue disease|Mixed connective-tissue disease]]
*[[Tumors]] such as  
*[[Tumors]] such as  
**[[Hepatocellular carcinoma|Hepatocellular carcinoma (HCC)]]  
**[[Hepatocellular carcinoma|Hepatocellular carcinoma (HCC)]]  
Line 44: Line 42:
**[[Wilms' tumor|Wilms tumor]]
**[[Wilms' tumor|Wilms tumor]]
**[[Right atrial myxoma]]
**[[Right atrial myxoma]]
*[[Congenital]] membranous obstructions that includes the following:
*[[Congenital]] membranous obstructions that include the following:
**Type I: Thin membrane is present in the [[vena cava]] or the [[atrium]]
**Type I: Thin membrane is present in the [[vena cava]] or the [[atrium]]
**Type II: A part of the [[vena cava]] is absent
**Type II: A part of the [[vena cava]] is absent
Line 55: Line 53:
**[[Postsurgical]] [[obstruction]]
**[[Postsurgical]] [[obstruction]]
**Posttraumatic [[obstruction]]
**Posttraumatic [[obstruction]]
**[[Total parenteral nutrition|Total parenteral nutrition (TPN)]]: Budd-Chiari syndrome can be a [[complication]] of [[TPN]] via an [[Inferior vena cava|IVC]] [[catheter]] in a [[neonate]]
**[[Total parenteral nutrition|Total parenteral nutrition (TPN)]]: Budd-Chiari syndrome can be a [[complication]] of [[total parenteral nutrition]] ([[TPN]]) via an [[inferior vena cava]] ([[Inferior vena cava|IVC]]) [[catheter]] in a [[neonate]]


==References==
==References==

Latest revision as of 18:02, 30 November 2017

Budd-Chiari syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Budd-Chiari syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Budd-Chiari syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Budd-Chiari syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Budd-Chiari syndrome risk factors

CDC on Budd-Chiari syndrome risk factors

Budd-Chiari syndrome risk factors in the news

Blogs on Budd-Chiari syndrome risk factors

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Budd-Chiari syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overivew

Approximately 80 percent of patients with the Budd-Chiari syndrome have an underlying disorder. Many patients may have more than one risk factor. Same patients may have multiple causes that predispose to the development of Budd-Chiari Syndrome. Associated risk factors include hematologic disorders, coagulopathies, chronic infections, chronic inflammatory diseases, tumors, congenital membranous obstructions.

Risk Factors

References

  1. Martens P, Nevens F (2015). "Budd-Chiari syndrome". United European Gastroenterol J. 3 (6): 489–500. doi:10.1177/2050640615582293. PMC 4669515. PMID 26668741.
  2. Shin N, Kim YH, Xu H, Shi HB, Zhang QQ, Colon Pons JP, Kim D, Xu Y, Wu FY, Han S, Lee BB, Li LS (2016). "Redefining Budd-Chiari syndrome: A systematic review". World J Hepatol. 8 (16): 691–702. doi:10.4254/wjh.v8.i16.691. PMC 4909431. PMID 27326316.

Template:WS Template:WH